A carregar...
RAS, wanted dead or alive: Advances in targeting RAS-mutant cancers
Oncogenic RAS proteins, which are mutated in approximately 24% of all human cancers, have earned a well-deserved reputation as being “undruggable.” However, several studies have challenged that reputation. With the first small molecules that directly target one oncogenic RAS mutant (G12C) undergoing...
Na minha lista:
| Publicado no: | Sci Signal |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393681/ https://ncbi.nlm.nih.gov/pubmed/32209699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aay6013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|